Genetics and Pathogenic of (SARS-Covid-19) Coronavirus (Article Review)
DOI:
https://doi.org/10.46966/msjar.v4i3.138Keywords:
Human coronavirus, (SARS-CoV), Genetics and Pandamic COVID-19Abstract
Background: Coronaviruses are a group of enveloped viruses with non-segmented, single-stranded, and positive-sense RNA genomes. These viruses can infect various important vertebrates such as pigs and chickens, as well as humans, causing respiratory diseases. Among them, there are two highly pathogenic coronaviruses that have resulted in global outbreaks: the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV). The name "coronavirus" comes from the outer fringe, or "corona," of embedded envelope protein. The Coronaviridae family can cause a wide range of animal and human diseases. The RNA genome replication process is unique in that it generates a nested set of viral mRNA molecules. Human coronavirus (H-CoV) infection can cause respiratory diseases with varying degrees of severity. COVID-19 can cause a variety of symptoms that vary in severity. While many cases may not result in any symptoms or only mild ones, some patients may experience a more severe form of the disease that can lead to acute respiratory distress syndrome and other complications affecting multiple organs.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 ijdan Rajh Hamza Al-Kraity; Hawraa Natiq Kabroot AL-Fatlawy, Zainab Sajid Mohammed

This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Medical Science Journal for Advance Research agree to the following terms:
- Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.


















